Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.
about
Targeted DNA mutagenesis for the cure of chronic viral infectionsEpigenetic control of HIV-1 post integration latency: implications for therapyVitamin D receptor and epigenetics in HIV infection and drug abuseTranscriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cureHuman immunodeficiency virus (HIV)-1 integration sites in viral latencyAchieving HIV-1 Control through RNA-Directed Gene RegulationPhosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytesA Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNPLatency reversal and viral clearance to cure HIV-1.Eradication therapies for HIV Infection: time to begin again.Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription.Combinatorial latency reactivation for HIV-1 subtypes and variantsThe Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assemblyProtein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathwayTranscriptional and posttranscriptional regulation of HIV-1 gene expressionSnapshots: chromatin control of viral infection.Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapyThe molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.Interaction between endogenous bacterial flora and latent HIV infection.Impact of the Ku complex on HIV-1 expression and latency.Pharmaceutical approaches to eradication of persistent HIV infection.Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.An upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.Viral-host interactions that control HIV-1 transcriptional elongationT-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.Selective HDAC inhibition for the disruption of latent HIV-1 infection.A hardwired HIV latency program.Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription.Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1.Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTRH3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-κB mediated viral gene expressionHIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication
P2860
Q24620150-CBD400C7-01BF-4E57-812A-6C6156D0804AQ26781191-A99EA887-B486-4718-8AF8-45EE571910A2Q26782833-6503A83A-7296-4262-9E3A-A23A8D5267C8Q26999858-B94C15E4-2588-42E9-AB95-07C499139E17Q27026246-15CDBD84-F45F-4B64-8F2C-560959012653Q28080090-922EF49A-1FE2-445B-BF51-53BF3DEC9A27Q28487524-1421B510-0041-42EB-A3B8-4648264AA2EEQ28550986-62A0D7F0-7550-427F-A8F9-10510DD77912Q30248766-E3BEF091-1935-4355-BEEC-CFCBCB0096E7Q30399588-9B16C9B2-10CD-416F-B311-16746CA8BD47Q33602605-E65E20EF-3F09-443A-BF16-01E52D936D6BQ33724213-ECA49630-3079-42C2-9796-D04B8DB2F2A1Q33877492-57E0D783-C175-4DF5-A26C-EF6BEB01D1EFQ33893725-8E0BEC2C-6BC9-441A-B811-C809A7DF70FFQ34022422-974B147E-87BF-4F9F-9181-9325CEB4E852Q34030804-C28FEBF5-833D-4243-9999-E0F0F73172DCQ34315920-81E569AD-2625-4599-AD99-4C64BFE86BF4Q34384134-299802B2-F887-4205-8B99-8633DE311264Q34544409-5B397688-4461-41C5-A9A6-9339DB26B82AQ34656952-199E7A20-32A6-4FA4-A9FF-571C3805B63DQ34686713-1A2575C3-EA7B-434A-9A16-CB9918DAA495Q34903532-93EA91A3-F5EF-42B4-8470-82C886847411Q34941973-9494B621-D14C-4CE0-9A37-1675D0410383Q34986080-026CF97A-9A71-4A49-8FAB-153603A91691Q35015033-60406205-DF45-4CFB-ADA4-EE0BA373A555Q35026881-772E4C0C-3554-424F-99D2-2EEE51A2847AQ35113716-488C5B84-5B32-4954-A35A-D89984BEAFE5Q35192959-8C35198C-F678-4E0B-BEF8-8021B6FCD523Q35227888-C087E17E-4CC3-44D8-97B6-65B7C14E4B89Q35400385-FED532B4-B45F-4931-B47F-20A156B7E6A5Q35842547-B1481699-A393-47AE-BC93-5D33DF713ECBQ35856911-7E28DF11-DBAD-4B2D-875A-5905504B2A43Q35894061-B04F7F2F-3A54-4E8E-8D58-31638A818739Q35914266-FD031FBF-5B18-46F1-AF53-3D919B45066CQ35996134-B5DD8AD9-9A7B-47BD-BCAA-C7ADD3357ACDQ36121883-E1FD3E0A-E87C-4B0B-A4A8-712E6CDFB1A3Q36198250-A87C5576-4BC2-4578-B829-3484D450C17EQ36202761-67948E56-4474-4D87-A493-33E8D8614213Q36313032-9A5476B0-C9FB-4F6F-A554-5EB53E6EF707Q36330062-49568441-FE62-49DE-8AD3-FE389DE19BF3
P2860
Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Epigenetic silencing of human ...... ive entry of HIV into latency.
@en
Epigenetic silencing of human immunodeficiency virus
@nl
type
label
Epigenetic silencing of human ...... ive entry of HIV into latency.
@en
Epigenetic silencing of human immunodeficiency virus
@nl
prefLabel
Epigenetic silencing of human ...... ive entry of HIV into latency.
@en
Epigenetic silencing of human immunodeficiency virus
@nl
P2093
P2860
P356
P1433
P1476
Epigenetic silencing of human ...... ive entry of HIV into latency.
@en
P2093
Jonathan Karn
Joseph Hokello
Julia Friedman
Kara Lassen
Mudit Tyagi
Richard Pearson
Young Kyeung Kim
P2860
P304
12291-12303
P356
10.1128/JVI.01383-08
P407
P577
2008-10-01T00:00:00Z